Close

Mizuho Securities Cuts Price Target on Allergan (AGN) to $299 Ahead of 3Q Report

October 11, 2016 7:16 AM EDT Send to a Friend
Mizuho Securities maintained a Buy rating on Allergen (NYSE: AGN), and cut the price target to $299.00 (from $305.00), ahead ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login